Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 04, 2021

SELL
$99.52 - $215.83 $3.11 Million - $6.74 Million
-31,248 Closed
0 $0
Q4 2020

Feb 03, 2021

SELL
$80.55 - $106.05 $672,592 - $885,517
-8,350 Reduced 21.09%
31,248 $3.11 Million
Q3 2020

Nov 12, 2020

SELL
$89.56 - $126.72 $1.58 Million - $2.23 Million
-17,616 Reduced 30.79%
39,598 $3.78 Million
Q2 2020

Aug 05, 2020

SELL
$68.28 - $123.65 $318,116 - $576,085
-4,659 Reduced 7.53%
57,214 $6.4 Million
Q1 2020

May 13, 2020

SELL
$63.37 - $107.88 $512,853 - $873,072
-8,093 Reduced 11.57%
61,873 $4.5 Million
Q4 2019

Feb 05, 2020

SELL
$96.94 - $113.59 $826,025 - $967,900
-8,521 Reduced 10.86%
69,966 $7.3 Million
Q3 2019

Nov 07, 2019

SELL
$86.25 - $120.16 $2.97 Million - $4.14 Million
-34,415 Reduced 30.48%
78,487 $7.81 Million
Q2 2019

Aug 14, 2019

SELL
$107.38 - $129.34 $1.39 Million - $1.67 Million
-12,939 Reduced 10.28%
112,902 $12.9 Million
Q1 2019

May 09, 2019

SELL
$105.93 - $142.47 $7.83 Million - $10.5 Million
-73,927 Reduced 37.01%
125,841 $15.8 Million
Q4 2018

Feb 11, 2019

SELL
$128.36 - $272.13 $1.52 Million - $3.23 Million
-11,880 Reduced 5.61%
199,768 $27.1 Million
Q3 2018

Nov 07, 2018

SELL
$211.18 - $274.49 $3.06 Million - $3.98 Million
-14,486 Reduced 6.41%
211,648 $58.1 Million
Q2 2018

Aug 13, 2018

SELL
$150.77 - $207.98 $3.17 Million - $4.38 Million
-21,048 Reduced 8.52%
226,134 $46.8 Million
Q1 2018

May 14, 2018

SELL
$138.63 - $182.62 $10.2 Million - $13.5 Million
-73,890 Reduced 23.01%
247,182 $40.8 Million
Q4 2017

Feb 13, 2018

SELL
$128.36 - $147.04 $14.8 Million - $17 Million
-115,636 Reduced 26.48%
321,072 $44 Million
Q3 2017

Nov 07, 2017

SELL
$120.91 - $137.94 $15.6 Million - $17.8 Million
-129,394 Reduced 22.86%
436,708 $59.5 Million
Q2 2017

Aug 10, 2017

BUY
N/A
566,102
566,102 $68.7 Million

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $2.03B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Oak Ridge Investments LLC Portfolio

Follow Oak Ridge Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.